Prerpints.org logo
Preprint
Article

Artificial Intelligence-based Mammogram Analysis for Early Detection

Altmetrics

Downloads

160

Views

63

Comments

0

This version is not peer-reviewed

Submitted:

13 December 2023

Posted:

14 December 2023

You are already at the latest version

Alerts
Abstract
The article focuses on breast cancer, mammography, and artificial intelligence. First, breast cancer is a widespread health problem that affects millions of people worldwide, and mammography is a widely adopted screening method. Then it introduced the advantages of mammography after AI participation, and introduced the importance of early detection of breast cancer and the application of artificial intelligence in breast cancer detection and treatment. From these aspects extend to the entire medical field of artificial intelligence issues. Several times throughout the paper, ethical issues that could arise from applying AI to healthcare are highlighted. At the end of the article, the paper describes the continued development of AI-based mammography analysis over the next period of time.
Keywords: 
Subject: Computer Science and Mathematics  -   Artificial Intelligence and Machine Learning

1. Introduction of Mammogram Analysis

Breast cancer is a prevalent health concern affecting millions of individuals globally[1]. Early detection remains a critical factor in improving treatment outcomes and survival rates[2]. As shown in Table 1 below, in addition to regular breast self-examination or clinical examination by a professional doctor, the different cancer screening methods for breast cancer include mammography, Sonography screening, and breast magnetic resonance imaging (MRI) Scan[3]. Mammography, a widely adopted screening method, involves the use of X-ray images to visualize breast tissue abnormalities[4]. However, the interpretation of mammograms can be complex, requiring a high level of expertise from radiologists. In recent years, the integration of artificial intelligence (AI) in mammogram analysis has emerged as a promising approach to enhance the accuracy and efficiency of breast cancer detection[5].
The advent of AI in mammogram analysis has ushered in a new era of diagnostic precision[6]. Machine learning algorithms, trained on vast datasets of annotated mammograms, can recognize subtle patterns and anomalies that may be indicative of early-stage breast cancer[7]. These algorithms have demonstrated the capacity to assist radiologists by highlighting areas of concern, reducing the risk of oversight, and ultimately improving diagnostic accuracy. The augmentation of human expertise with AI-driven tools holds the potential to revolutionize the early detection landscape, enabling prompt intervention and personalized treatment strategies[8].
One of the primary advantages of AI in mammogram analysis lies in its ability to handle large volumes of data efficiently. AI algorithms can rapidly process and analyze countless mammographic images, providing a scalable solution to the growing demand for breast cancer screening[9]. Moreover, the integration of deep learning techniques allows these algorithms to continuously learn and adapt, refining their performance over time. This iterative learning process contributes to ongoing improvements in the sensitivity and specificity of mammogram analysis, addressing the challenges associated with false positives and false negatives[10].
While the implementation of AI in mammogram analysis shows great promise, it also brings forth important considerations. Ethical concerns, including patient privacy, algorithmic biases, and the need for robust validation studies, must be carefully addressed to ensure the responsible and equitable deployment of these technologies in clinical settings[11]. As research and development in this field progress, the collaboration between healthcare professionals and AI systems in mammogram analysis has the potential to redefine standards in breast cancer screening, ultimately contributing to more effective and accessible healthcare solutions[12].

2. Importance of Early Detection in Breast Cancer

The importance of early detection in breast cancer cannot be overstated, as it significantly influences the prognosis and treatment outcomes for individuals affected by this prevalent form of cancer[13]. Early detection allows for the identification of tumors at smaller sizes, often before they have spread to surrounding tissues or lymph nodes[14]. This is crucial because smaller, localized tumors are generally more treatable and associated with a higher likelihood of successful intervention [15]. Timely detection can lead to less aggressive treatment options, potentially reducing the physical and emotional burden on patients.
Early detection is primarily facilitated through routine screening programs, with mammography being a cornerstone in breast cancer screening[16]. Mammograms can detect abnormalities such as microcalcifications or masses that may be indicative of cancerous growths before they are palpable or symptomatic[17]. As breast cancer at an early stage may not present noticeable symptoms, regular screening becomes a proactive strategy to catch potential malignancies in their initial phases[18]. Early detection is especially critical in the context of breast cancer, where the disease can progress rapidly, underscoring the importance of identifying and addressing it at the earliest possible stage [19].
Beyond the individual impact, early detection also holds broader implications for public health. By identifying and treating breast cancer at an early stage, the overall burden on the healthcare system is reduced[20]. The cost of treatment for early-stage breast cancer is often lower than that for advanced stages, emphasizing the economic efficiency of early detection [21]. According to a study published by the National Center for Biotechnology Information (NCBI) in 2020, the average treatment cost of breast cancer is closely related to its stage of development, as shown in Figure 1, 0-4 indicates the symptoms of breast cancer from mild to severe, and the cost of treatment rises accordingly[22]. Additionally, early detection contributes to improved survival rates and quality of life for patients, emphasizing the societal benefits of proactive screening initiatives and the importance of raising awareness about the significance of early detection in breast cancer[23].

3. Artificial Intelligence in Healthcare

Artificial Intelligence (AI) in healthcare refers to the application of advanced computational algorithms and machine learning techniques to analyze complex medical data, make predictions, and assist healthcare professionals in decision-making processes[24]. The integration of AI technologies in healthcare settings has the potential to transform various aspects of the industry, from diagnostics and treatment planning to patient care and administrative tasks[25]. The current application of AI in healthcare is shown in Figure 2.
One significant area where AI is making a substantial impact is in medical imaging[26]. AI algorithms can analyze medical images, such as X-rays, MRIs, and CT scans, to identify patterns and anomalies that may be indicative of diseases like cancer or abnormalities in organs[27]. This not only aids radiologists in making more accurate and efficient diagnoses but also contributes to early detection and intervention.
In diagnostics and personalized medicine, AI is being utilized to analyze vast datasets, including genomic information and patient records[28]. Machine learning algorithms can identify patterns and correlations that may be challenging for human experts to discern, leading to more precise diagnoses and tailored treatment plans based on individual patient characteristics.
Another application of AI in healthcare is in predictive analytics. By analyzing historical patient data, AI systems can predict disease risks and outcomes, enabling proactive and preventive interventions[29]. This has the potential to improve patient outcomes and reduce healthcare costs by addressing issues before they become more severe.
AI-driven chatbots and virtual assistants are being employed to enhance patient engagement and support[30]. These technologies can provide information, answer queries, and offer basic medical advice, improving accessibility to healthcare resources and promoting patient education[30].
However, the integration of AI in healthcare is not without challenges. Ethical considerations, data privacy, and regulatory compliance are critical issues that need careful attention[31]. Ensuring the fairness and transparency of AI algorithms, addressing biases, and maintaining the security of sensitive health information are paramount for the responsible implementation of AI in healthcare[32].

4. AI in Breast Cancer Diagnosis and Treatment

Artificial Intelligence (AI) is playing a transformative role in revolutionizing the field of breast cancer diagnosis and treatment[25]. In the context of breast cancer, AI technologies are applied to enhance the accuracy, speed, and efficiency of various processes, ranging from early detection to personalized treatment strategies[33]. The integration of AI in this domain aims to address challenges in interpreting complex medical data, improve diagnostic precision, and contribute to more tailored and effective therapeutic approaches [34].
As illustrated in Figure 3, AI in the cancer research process is mainly divided into three parts: early and accurate diagnosis, cancer treatment, and prediction of cancer incidence, cancer recurrence, and cancer survival[35]. In the face of early cancer, doctors diagnose the patient's condition through various AI-based auxiliary detection means [36]. After diagnosis, we will use artificial intelligence for drug research and assisted surgery and other technologies to treat cancer.
AI, particularly machine learning algorithms, is deployed in the analysis of vast datasets, including mammograms, genetic information, and clinical records, to identify patterns and markers associated with breast cancer[37]. These algorithms can learn from diverse datasets, distinguishing between normal and abnormal findings, and assist healthcare professionals in diagnosing breast cancer at its early stages [38]. The ability of AI to process and interpret large volumes of data rapidly contributes to more timely and accurate diagnoses, which is crucial for initiating prompt interventions and improving patient outcomes[39]. The content in Figure 4 shows the application steps of mammogram analysis in breast cancer detection.
Beyond diagnosis, AI plays a pivotal role in tailoring treatment plans for breast cancer patients[35]. By analyzing individual patient data, including genetic information and treatment outcomes, AI can identify optimal therapeutic strategies[40]. This approach, often referred to as precision medicine, aims to maximize treatment efficacy while minimizing side effects. AI-driven models assist oncologists in selecting targeted therapies based on the unique characteristics of the patient's cancer [41], ultimately contributing to more effective and personalized treatment regimens[40].
While the application of AI in breast cancer diagnosis and treatment holds immense promise, challenges such as ethical considerations, data privacy, and the need for robust validation persist. Ensuring the reliability and interpretability of AI models, addressing biases in training data, and navigating regulatory frameworks are ongoing areas of concern[42]. Future directions in this field involve continued research to refine AI algorithms, expand datasets for training, and establish collaborative frameworks that integrate AI seamlessly into clinical workflows[43]. The evolving landscape of AI in breast cancer underscores its potential to reshape the standard of care, providing a more nuanced and patient-centric approach to diagnosis and treatment.

5. Machine Learning Algorithms in Mammogram Interpretation

Machine learning (ML) [44] algorithms play a pivotal role in the interpretation of mammograms, significantly enhancing the efficiency and accuracy of breast cancer detection. Mammography, a key tool in breast cancer screening [45], produces complex images that require expert analysis[46]. ML algorithms, as a subset of artificial intelligence, are designed to learn patterns from large datasets, enabling automated interpretation of mammographic images[5]. The application of ML in mammogram interpretation aims to assist radiologists by identifying subtle abnormalities indicative of early-stage breast cancer.
Several types of machine learning algorithms are employed in mammogram interpretation, each offering unique capabilities. Machine learning algorithms can be divided into supervised learning and unsupervised learning[47]. The differences between the two different learning methods are shown in Table 2. For this reason, different effects will be produced in the end [48]. Supervised learning is commonly used, where algorithms are trained on labeled datasets containing mammograms with known outcomes (e.g., cancer or non-cancer). These algorithms learn to recognize patterns associated with breast cancer, allowing them to classify new, unseen images. Convolutional Neural Networks (CNNs), a type of deep learning algorithm, have demonstrated remarkable success in image recognition tasks and are increasingly utilized in mammogram analysis[49]. Unsupervised learning, on the other hand, involves algorithms identifying patterns without pre-existing labels, potentially revealing novel insights in mammogram datasets.
The training of ML models in mammogram interpretation involves exposing the algorithm to a diverse dataset that includes both normal and cancerous cases[50]. The algorithm learns to distinguish between these cases by adjusting its parameters to minimize errors. Validation of these models is crucial to assess their generalizability and performance on new, unseen data. Rigorous validation processes help ensure that the ML algorithm can reliably identify abnormalities in diverse mammographic images, contributing to the robustness of the model in real-world clinical settings.
One of the primary objectives of integrating ML algorithms in mammogram interpretation is to improve both sensitivity and specificity[51]. Sensitivity refers to the ability to correctly identify true positive cases (e.g., detecting breast cancer when it is present), while specificity pertains to the capacity to correctly identify true negative cases (e.g., correctly identifying cases as non-cancerous). The sensitivity and specificity are calculated as shown in Table 3. Usually, there is a trade-off between sensitivity and specificity, that is, the higher the sensitivity, the lower the specificity, and vice versa. ML algorithms aim to strike a balance between these metrics, reducing false positives and false negatives. Enhanced sensitivity ensures that fewer cases of breast cancer go undetected, while improved specificity reduces unnecessary follow-up procedures for benign findings[52].
S e n s i t i v i t y = T P T P + F N
S p e c i f i c i t y = T N F P + T N
Despite the remarkable advancements, challenges persist in the deployment of ML algorithms for mammogram interpretation. Ensuring the diversity and representativeness of training datasets, addressing biases, and validating performance across different populations are ongoing concerns[53]. Ethical considerations, including patient privacy and transparency in algorithmic decision-making, also require careful attention. The collaboration between AI algorithms and human radiologists in mammogram interpretation represents a promising synergy, where the strengths of both can be leveraged for more accurate and efficient breast cancer screening.

6. Ethical Issues in AI-Driven Healthcare

The integration of Artificial Intelligence (AI) in healthcare has introduced a range of ethical considerations that necessitate careful examination. As AI technologies, including machine learning algorithms, become increasingly involved in medical decision-making, there is a need to address issues related to transparency, accountability, patient privacy, and equity. Section 6 focuses on the ethical challenges arising in the context of AI-driven healthcare, highlighting the importance of navigating these issues for the responsible deployment of technology in the medical domain.
One of the foremost ethical concerns in AI-driven healthcare is the safeguarding of patient privacy and the secure handling of sensitive medical data[54]. AI algorithms often rely on vast datasets for training and validation, including patient records, images, and genomic information. Ensuring that these datasets are de-identified and anonymized is critical to protect patient privacy. Moreover, healthcare institutions must implement robust data security measures to prevent unauthorized access, breaches, or misuse of patient information[55]. Ethical guidelines and regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, play a crucial role in defining standards for data privacy in AI-driven healthcare.
The potential for algorithmic bias in AI-driven healthcare systems is a significant ethical concern. If training data used to develop AI models are not representative or if they contain biases, the algorithms may produce results that disproportionately impact certain demographic groups[42]. This bias can lead to disparities in diagnosis, treatment recommendations, and healthcare outcomes. Ensuring fairness and equity in AI algorithms requires ongoing efforts to identify and mitigate biases, as well as transparent reporting of how algorithms function. Additionally, addressing bias involves diversifying the datasets used for training to encompass a wide range of demographics and ensuring that AI systems are validated across diverse populations[56].
Maintaining transparency in AI-driven healthcare is vital to uphold the principles of informed consent and shared decision-making. Patients have the right to understand how AI algorithms contribute to their diagnosis, treatment plans, and overall healthcare[57]. Transparency involves providing clear information about the role of AI in decision support, the limitations of the technology, and potential uncertainties. Additionally, obtaining informed consent from patients before implementing AI technologies in their care is essential. Open communication between healthcare providers and patients builds trust and ensures that individuals are aware of how AI is utilized in their treatment.
Another ethical consideration involves defining the roles and responsibilities of healthcare professionals in the context of AI-driven healthcare. Clinicians must maintain a level of oversight and interpretability in AI-generated recommendations, avoiding blind reliance on algorithms[58]. Ethical guidelines and professional standards should be established to guide healthcare practitioners in incorporating AI into their decision-making processes responsibly. Collaboration between AI systems and human experts ensures a balance between the capabilities of technology and the nuanced understanding and empathy that human healthcare providers bring to patient care[59]. Striking this balance requires ongoing dialogue, education, and a commitment to ethical practices in the evolving landscape of AI-driven healthcare.

7. Ongoing Developments in AI-Based Mammogram Analysis

Section 7 delves into the dynamic landscape of ongoing developments in AI-based mammogram analysis, highlighting the continuous evolution of technology and methodologies. As the field of artificial intelligence in healthcare advances, researchers and practitioners are exploring new approaches, refining existing algorithms, and addressing challenges to enhance the effectiveness of mammogram analysis for breast cancer detection. This section sheds light on the latest trends, innovations, and research frontiers that are shaping the future of AI in mammography.
Ongoing developments in AI-based mammogram analysis involve the integration of multi-modal data and the incorporation of advanced imaging techniques[60]. Researchers are exploring the synergy of mammography with other imaging modalities such as ultrasound, magnetic resonance imaging (MRI), and molecular imaging[61]. The combination of information from multiple sources can provide a more comprehensive view of breast tissue, potentially improving the accuracy of cancer detection and characterization. Furthermore, advancements in imaging technology, such as tomosynthesis and quantitative imaging, offer richer datasets for AI algorithms to analyze, contributing to more nuanced and precise mammogram interpretations.
Continued research aims to enhance the diagnostic precision of AI algorithms in mammogram analysis. This involves refining machine learning models to better differentiate between benign and malignant findings, reducing false positives and false negatives. Additionally, the integration of AI into clinical decision support systems is evolving, providing radiologists with real-time assistance and supplementary insights during the interpretation of mammograms[62]. Ongoing developments focus on creating seamless workflows where AI augments the expertise of healthcare professionals, contributing to more accurate and efficient breast cancer diagnoses[63].

8. Conclusions

In conclusion, the integration of artificial intelligence (AI) into breast cancer diagnosis and treatment, particularly in the context of mammogram analysis, represents a transformative leap forward in healthcare[64]. The ongoing developments in AI-based mammogram analysis underscore the commitment of researchers and healthcare professionals to enhancing early detection, improving diagnostic accuracy, and ultimately advancing patient outcomes[63]. The convergence of machine learning algorithms with multi-modal imaging data[65], such as tomosynthesis and advanced imaging techniques, is expanding the horizons of breast cancer screening, providing a more comprehensive understanding of breast tissue characteristics.
The benefits of AI in mammogram analysis are evident in its potential to augment the capabilities of radiologists, offering real-time clinical decision support and contributing to more personalized and effective treatment strategies. As we navigate this technological frontier, it is crucial to remain mindful of the ethical considerations that accompany the integration of AI in healthcare. Ensuring patient privacy, addressing algorithmic biases, and maintaining transparency are paramount to fostering trust between patients, healthcare providers, and AI systems[66].
The journey toward the widespread adoption of AI in mammogram analysis is marked by collaborative efforts to overcome challenges, both technical and ethical. Ongoing research is not only refining the diagnostic precision of AI algorithms but also actively addressing implementation challenges, such as interoperability and the seamless integration of AI into existing healthcare frameworks. As the field continues to evolve, the promise of AI-based mammogram analysis lies not only in its potential to revolutionize breast cancer screening but also in its ability to contribute to a more patient-centric, efficient, and equitable healthcare landscape[67]. The ongoing commitment to innovation and ethical practice ensures that the benefits of AI in breast cancer care are harnessed responsibly for the betterment of public health.

Funding

This research did not receive any grants.

Acknowledgment

We thank all the anonymous reviewers for their hard reviewing work.

References

  1. L. Wilkinson and T. Gathani, "Understanding breast cancer as a global health concern," The British Journal of Radiology, vol. 95, p. 20211033, 2022. [CrossRef]
  2. Y. X. Lim, Z. L. Lim, P. J. Ho, and J. Li, "Breast cancer in Asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives," Cancers, vol. 14, p. 4218, 2022. [CrossRef]
  3. R. A. Dar, M. Rasool, and A. Assad, "Breast cancer detection using deep learning: Datasets, methods, and challenges ahead," Computers in biology and medicine, p. 106073, 2022.
  4. R. M. Al-Tam, A. M. Al-Hejri, S. M. Narangale, N. A. Samee, N. F. Mahmoud, M. A. Al-Masni, et al., "A hybrid workflow of residual convolutional transformer encoder for breast cancer classification using digital X-ray mammograms," Biomedicines, vol. 10, p. 2971, 2022. [CrossRef]
  5. S. M. Shah, R. A. Khan, S. Arif, and U. Sajid, "Artificial intelligence for breast cancer analysis: Trends & directions," Computers in Biology and Medicine, vol. 142, p. 105221, 2022. [CrossRef]
  6. S. Saxena, B. Jena, N. Gupta, S. Das, D. Sarmah, P. Bhattacharya, et al., "Role of artificial intelligence in radiogenomics for cancers in the era of precision medicine," Cancers, vol. 14, p. 2860, 2022. [CrossRef]
  7. A. H. George, A. Shahul, and A. S. George, "Artificial Intelligence in Medicine: A New Way to Diagnose and Treat Disease," Partners Universal International Research Journal, vol. 2, pp. 246-259, 2023. [CrossRef]
  8. J. Iqbal, D. C. C. Jaimes, P. Makineni, S. Subramani, S. Hemaida, T. R. Thugu, et al., "Reimagining healthcare: unleashing the power of artificial intelligence in medicine," Cureus, vol. 15, 2023. [CrossRef]
  9. A. Guerrisi, I. Falcone, F. Valenti, M. Rao, E. Gallo, S. Ungania, et al., "Artificial intelligence and advanced melanoma: treatment management implications," Cells, vol. 11, p. 3965, 2022. [CrossRef]
  10. S. Bhat, A. Mansoor, B. Georgescu, A. B. Panambur, F. C. Ghesu, S. Islam, et al., "AUCReshaping: improved sensitivity at high-specificity," Scientific Reports, vol. 13, p. 21097, 2023. [CrossRef]
  11. C. Burr and D. Leslie, "Ethical assurance: a practical approach to the responsible design, development, and deployment of data-driven technologies," AI and Ethics, vol. 3, pp. 73-98, 2023. [CrossRef]
  12. C. Leibig, M. Brehmer, S. Bunk, D. Byng, K. Pinker, and L. Umutlu, "Combining the strengths of radiologists and AI for breast cancer screening: a retrospective analysis," The Lancet Digital Health, vol. 4, pp. e507-e519, 2022. [CrossRef]
  13. A. Roheel, A. Khan, F. Anwar, Z. Akbar, M. F. Akhtar, M. Imran Khan, et al., "Global epidemiology of breast cancer based on risk factors: a systematic review," Frontiers in Oncology, vol. 13, p. 1240098, 2023. [CrossRef]
  14. D. Crosby, S. Bhatia, K. M. Brindle, L. M. Coussens, C. Dive, M. Emberton, et al., "Early detection of cancer," Science, vol. 375, p. eaay9040, 2022. [CrossRef]
  15. Y.-D. Zhang, "Computer-aided diagnosis of abnormal breasts in mammogram images by weighted-type fractional Fourier transform," Advances in Mechanical Engineering, vol. 8, Article ID: 11, 2016. [CrossRef]
  16. W. H. Organization, Global breast cancer initiative implementation framework: assessing, strengthening and scaling-up of services for the early detection and management of breast cancer: World Health Organization, 2023.
  17. M. Zhang, B. Mesurolle, M. Theriault, S. Meterissian, and E. A. Morris, "Imaging of breast cancer–beyond the basics," Current Problems in Cancer, vol. 47, p. 100967, 2023. [CrossRef]
  18. R. C. Fitzgerald, A. C. Antoniou, L. Fruk, and N. Rosenfeld, "The future of early cancer detection," Nature medicine, vol. 28, pp. 666-677, 2022. [CrossRef]
  19. Y. Zhang, "Smart detection on abnormal breasts in digital mammography based on contrast-limited adaptive histogram equalization and chaotic adaptive real-coded biogeography-based optimization," Simulation, vol. 92, pp. 873-885, 2016. [CrossRef]
  20. D. Trapani, O. Ginsburg, T. Fadelu, N. U. Lin, M. Hassett, A. M. Ilbawi, et al., "Global challenges and policy solutions in breast cancer control," Cancer treatment reviews, vol. 104, p. 102339, 2022. [CrossRef]
  21. S. Wang, "Abnormal Breast Detection in Mammogram Images by Feed-forward Neural Network Trained by Jaya Algorithm," Fundamenta Informaticae, vol. 151, pp. 191-211, 2017. [CrossRef]
  22. E. Amjad, S. Asnaashari, B. Sokouti, and S. Dastmalchi, "Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages," Scientific reports, vol. 10, p. 10816, 2020. [CrossRef]
  23. I. Ruiz-Rodríguez, I. Hombrados-Mendieta, A. Melguizo-Garín, and M. J. Martos-Méndez, "The importance of social support, optimism and resilience on the quality of life of cancer patients," Frontiers in Psychology, vol. 13, p. 833176, 2022. [CrossRef]
  24. M. Javaid, A. Haleem, R. P. Singh, R. Suman, and S. Rab, "Significance of machine learning in healthcare: Features, pillars and applications," International Journal of Intelligent Networks, vol. 3, pp. 58-73, 2022. [CrossRef]
  25. S. A. Alowais, S. S. Alghamdi, N. Alsuhebany, T. Alqahtani, A. I. Alshaya, S. N. Almohareb, et al., "Revolutionizing healthcare: the role of artificial intelligence in clinical practice," BMC Medical Education, vol. 23, p. 689, 2023. [CrossRef]
  26. N. Hasani, M. A. Morris, A. Rahmim, R. M. Summers, E. Jones, E. Siegel, et al., "Trustworthy artificial intelligence in medical imaging," PET clinics, vol. 17, pp. 1-12, 2022. [CrossRef]
  27. N. Rane, "Transformers for Medical Image Analysis: Applications, Challenges, and Future Scope," Challenges, and Future Scope (November 2, 2023), 2023.
  28. S. Quazi, "Artificial intelligence and machine learning in precision and genomic medicine," Medical Oncology, vol. 39, p. 120, 2022. [CrossRef]
  29. G. M. Dogheim and A. Hussain, "Patient Care through AI-driven Remote Monitoring: Analyzing the Role of Predictive Models and Intelligent Alerts in Preventive Medicine," Journal of Contemporary Healthcare Analytics, vol. 7, pp. 94-110, 2023.
  30. A. Aggarwal, C. C. Tam, D. Wu, X. Li, and S. Qiao, "Artificial Intelligence–Based Chatbots for Promoting Health Behavioral Changes: Systematic Review," Journal of Medical Internet Research, vol. 25, p. e40789, 2023. [CrossRef]
  31. G. Karimian, E. Petelos, and S. M. Evers, "The ethical issues of the application of artificial intelligence in healthcare: a systematic scoping review," AI and Ethics, vol. 2, pp. 539-551, 2022. [CrossRef]
  32. S. Prakash, J. N. Balaji, A. Joshi, and K. M. Surapaneni, "Ethical Conundrums in the application of artificial intelligence (AI) in healthcare—a scoping review of reviews," Journal of Personalized Medicine, vol. 12, p. 1914, 2022. [CrossRef]
  33. L. K. Singh, M. Khanna, and R. Singh, "Artificial intelligence based medical decision support system for early and accurate breast cancer prediction," Advances in Engineering Software, vol. 175, p. 103338, 2023. [CrossRef]
  34. Y.-D. Zhang, "Abnormal breast identification by nine-layer convolutional neural network with parametric rectified linear unit and rank-based stochastic pooling," Journal of Computational Science, vol. 27, pp. 57-68, 2018. [CrossRef]
  35. Liao, X. Li, Y. Gan, S. Han, P. Rong, W. Wang, et al., "Artificial intelligence assists precision medicine in cancer treatment," Frontiers in Oncology, vol. 12, p. 998222, 2023. [CrossRef]
  36. D. S. Guttery, "Abnormal breast detection by an improved AlexNet model," Annals of Oncology, vol. 31, p. S277, 2020. [CrossRef]
  37. A. Sahu, S. Qazi, K. Raza, A. Singh, and S. Verma, "Machine learning-based approach for early diagnosis of breast cancer using biomarkers and gene expression profiles," in Computational Intelligence in Oncology: Applications in Diagnosis, Prognosis and Therapeutics of Cancers, ed: Springer, 2022, pp. 285-306.
  38. Y.-D. Zhang, "Improved Breast Cancer Classification Through Combining Graph Convolutional Network and Convolutional Neural Network," Information Processing and Management, vol. 58, Article ID: 102439, 2021. [CrossRef]
  39. S. Sharma, "Artificial intelligence for fracture diagnosis in orthopedic X-rays: current developments and future potential," SICOT-J, vol. 9, 2023. [CrossRef]
  40. Z. Dlamini, A. Skepu, N. Kim, M. Mkhabele, R. Khanyile, T. Molefi, et al., "AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies-an outcomes based patient care," Informatics in Medicine Unlocked, vol. 31, p. 100965, 2022. [CrossRef]
  41. J. Wang, "SNSVM: SqueezeNet-Guided SVM for Breast Cancer Diagnosis," Computers, Materials \& Continua, vol. 76, pp. 2201--2216, 2023. [CrossRef]
  42. R. Schwartz, A. Vassilev, K. Greene, L. Perine, A. Burt, and P. Hall, "Towards a standard for identifying and managing bias in artificial intelligence," NIST special publication, vol. 1270, 2022.
  43. E. Badidi, "Edge AI for Early Detection of Chronic Diseases and the Spread of Infectious Diseases: Opportunities, Challenges, and Future Directions," Future Internet, vol. 15, p. 370, 2023. [CrossRef]
  44. S. Wang, "Pathological Brain Detection by a Novel Image Feature—Fractional Fourier Entropy," Entropy, vol. 17, pp. 8278-8296, 2015. [CrossRef]
  45. S. Wang, "Grad-CAM: understanding AI models," Computers, Materials & Continua, vol. 76, pp. 1321-1324, 2023. [CrossRef]
  46. P. Oza, P. Sharma, S. Patel, and P. Kumar, "Computer-aided breast cancer diagnosis: Comparative analysis of breast imaging modalities and mammogram repositories," Current Medical Imaging, vol. 19, pp. 456-468, 2023. [CrossRef]
  47. S. H. Shetty, S. Shetty, C. Singh, and A. Rao, "Supervised Machine Learning: Algorithms and Applications," Fundamentals and Methods of Machine and Deep Learning: Algorithms, Tools and Applications, pp. 1-16, 2022.
  48. S.-H. Wang, K. M. Attique, and G. Vishnuvarthanan, "Deep rank-based average pooling network for COVID-19 recognition," Computers, Materials, & Continua, vol. 70, pp. 2797-2813, 2022.
  49. H. Rahman, T. F. Naik Bukht, R. Ahmad, A. Almadhor, and A. R. Javed, "Efficient Breast Cancer Diagnosis from Complex Mammographic Images Using Deep Convolutional Neural Network," Computational intelligence and neuroscience, vol. 2023, 2023. [CrossRef]
  50. S. Safdar, M. Rizwan, T. R. Gadekallu, A. R. Javed, M. K. I. Rahmani, K. Jawad, et al., "Bio-imaging-based machine learning algorithm for breast cancer detection," Diagnostics, vol. 12, p. 1134, 2022. [CrossRef]
  51. A. W. Anderson, M. L. Marinovich, N. Houssami, K. P. Lowry, J. G. Elmore, D. S. Buist, et al., "Independent external validation of artificial intelligence algorithms for automated interpretation of screening mammography: a systematic review," Journal of the American College of Radiology, vol. 19, pp. 259-273, 2022. [CrossRef]
  52. T. Crook, R. Leonard, K. Mokbel, A. Thompson, M. Michell, R. Page, et al., "Accurate screening for early-stage breast cancer by detection and profiling of circulating tumor cells," Cancers, vol. 14, p. 3341, 2022. [CrossRef]
  53. D. Ueda, T. Kakinuma, S. Fujita, K. Kamagata, Y. Fushimi, R. Ito, et al., "Fairness of artificial intelligence in healthcare: review and recommendations," Japanese Journal of Radiology, pp. 1-13, 2023. [CrossRef]
  54. 54. M. Bilal Unver and O. Asan, "Role of Trust in AI-Driven Healthcare Systems: Discussion from the Perspective of Patient Safety," in Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 2022, pp. 129-134. [CrossRef]
  55. S. Duggineni, "Impact of Controls on Data Integrity and Information Systems," Science and Technology, vol. 13, pp. 29-35, 2023. [CrossRef]
  56. Y. Chen, E. W. Clayton, L. L. Novak, S. Anders, and B. Malin, "Human-centered design to address biases in artificial intelligence," Journal of Medical Internet Research, vol. 25, p. e43251, 2023. [CrossRef]
  57. M. Rezaei, E. Rahmani, S. J. Khouzani, M. Rahmannia, E. Ghadirzadeh, P. Bashghareh, et al., "Role of artificial intelligence in the diagnosis and treatment of diseases," Kindle, vol. 3, pp. 1-160, 2023.
  58. N. Hallowell, S. Badger, A. Sauerbrei, C. Nellåker, and A. Kerasidou, "“I don’t think people are ready to trust these algorithms at face value”: trust and the use of machine learning algorithms in the diagnosis of rare disease," BMC Medical Ethics, vol. 23, pp. 1-14, 2022.
  59. D. J. Monlezun, The Thinking Healthcare System: Artificial Intelligence and Human Equity: Elsevier, 2023.
  60. D. Zheng, X. He, and J. Jing, "Overview of artificial intelligence in breast cancer medical imaging," Journal of Clinical Medicine, vol. 12, p. 419, 2023. [CrossRef]
  61. B. Abhisheka, S. K. Biswas, B. Purkayastha, D. Das, and A. Escargueil, "Recent trend in medical imaging modalities and their applications in disease diagnosis: a review," Multimedia Tools and Applications, pp. 1-36, 2023. [CrossRef]
  62. B. Vasey, M. Nagendran, B. Campbell, D. A. Clifton, G. S. Collins, S. Denaxas, et al., "Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI," Nature medicine, vol. 28, pp. 924-933, 2022. [CrossRef]
  63. G. C. Saha, S. Kumar, A. Kumar, H. Saha, T. K. Lakshmi, and N. Bhat, "Human-AI Collaboration: Exploring interfaces for interactive Machine Learning," Tuijin Jishu/Journal of Propulsion Technology, vol. 44, p. 2023, 2023.
  64. K. Freeman, J. Geppert, C. Stinton, D. Todkill, S. Johnson, A. Clarke, et al., "Use of artificial intelligence for mammographic image analysis in breast cancer screening," Rapid review and evidence map, 2022.
  65. D. Quan, S. Wang, Y. Gu, R. Lei, B. Yang, S. Wei, et al., "Deep feature correlation learning for multi-modal remote sensing image registration," IEEE Transactions on Geoscience and Remote Sensing, vol. 60, pp. 1-16, 2022. [CrossRef]
  66. A. Albahri, A. M. Duhaim, M. A. Fadhel, A. Alnoor, N. S. Baqer, L. Alzubaidi, et al., "A systematic review of trustworthy and explainable artificial intelligence in healthcare: Assessment of quality, bias risk, and data fusion," Information Fusion, 2023.
  67. A. N. Gohar, S. A. Abdelmawgoud, and M. S. Farhan, "A patient-centric healthcare framework reference architecture for better semantic interoperability based on blockchain, cloud, and IoT," IEEE Access, vol. 10, pp. 92137-92157, 2022. [CrossRef]
Preprints 93247 g001
Figure 1. The average treatment cost of breast cancer in different stages.
Figure 1. The average treatment cost of breast cancer in different stages.
Preprints 93247 g001
Preprints 93247 g002
Figure 2. The application of artificial intelligence in healthcare.
Figure 2. The application of artificial intelligence in healthcare.
Preprints 93247 g002
Preprints 93247 g003
Figure 3. Artificial intelligence for cancer detection.
Figure 3. Artificial intelligence for cancer detection.
Preprints 93247 g003
Preprints 93247 g004
Figure 4. Mammogram analysis steps for breast cancer diagnosis.
Figure 4. Mammogram analysis steps for breast cancer diagnosis.
Preprints 93247 g004
Table 1. Methods and frequency of breast cancer screening.
Table 1. Methods and frequency of breast cancer screening.
Screening Method Population Risk Hereditary Risk
Clinical examination Once a year Every 6-12 months
Mammogram Once a year Once a year(or breast MRI scan)
Sonography screening No related suggestion No related suggestion
Breast MRI scan No related suggestion Once a year(or mammogram)
Table 2. Supervised learning versus unsupervised learning.
Table 2. Supervised learning versus unsupervised learning.
Supervised Unsupervised
Input data Labeled Unlabeled
Training Process Model receives input data and ground-truth label during training Model receives only input data without ground-truth label during training
General Purpose Predict an outcome Gain insight from the data
Computational Complexity Less computationally demanding More computationally demanding
Time Complexity More time consuming Less time consuming
Performance More accurate Less accurate
Number of Classes Known in advance Unknown, the result can be arbitrary
Table 3. Classification result confusion matrix.
Table 3. Classification result confusion matrix.
Truth Predict
Positive case Negative case
Positive case TP(True Positive) FN(False Negative)
Negative case FP(True Positive) TN(True Negative)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated